STOCK TITAN

Lifemd Inc - LFMD STOCK NEWS

Welcome to our dedicated page for Lifemd news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on Lifemd stock.

LifeMD, Inc. (LFMD) operates a leading telehealth platform connecting patients with HIPAA-compliant care solutions. This page serves as the definitive source for verified company news, providing investors and healthcare professionals with timely updates on key developments.

Access consolidated information on earnings reports, strategic partnerships, regulatory milestones, and service expansions. Our curated news collection simplifies tracking LFMD's progress in digital prescription services, remote diagnostics, and integrated telehealth solutions.

Discover updates across three core areas: financial performance announcements, operational developments in WorkSimpli software solutions, and advancements in secure patient-provider communication technologies. All content is sourced from official releases and trusted financial publications.

Bookmark this page for efficient monitoring of LifeMD's innovations in cloud-based pharmacy services, nutritional supplement offerings, and telehealth infrastructure. Return regularly to stay informed about this evolving leader in virtual healthcare delivery.

Rhea-AI Summary
LifeMD partners with ASCEND Therapeutics to provide integrated telehealth services for EstroGel® 0.06%
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.16%
Tags
conferences
-
Rhea-AI Summary
LifeMD reports record quarterly revenue of $35.9 million, up 18% YoY. Telehealth net revenues increased 11% from Q1 2023. Positive free cash flow achieved. Adjusted EBITDA increased to $1.7 million from a loss of $6.9 million in the year-ago period. Weight Management program expected to be accretive in 2024. Raised 2023 revenue guidance to $146 million to $152 million. Conference call at 4:30 p.m. Eastern time today.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.67%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) to Report Q2 2023 Financial Results on August 9, 2023. The leading provider of virtual primary care services will host a conference call at 4:30 p.m. Eastern time. Investors can access the live & archived webcast using the provided link.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.99%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.07%
Tags
dividends
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.66%
Tags
none
-
Rhea-AI Summary
LifeMD appoints William Febbo to its Board of Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.64%
Tags
management
-
Rhea-AI Summary
LifeMD, Inc. (NASDAQ: LFMD) will participate in the virtual June 1st Investor Summit. The conference is complimentary for qualified investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Lifemd Inc

Nasdaq:LFMD

LFMD Rankings

LFMD Stock Data

242.31M
36.24M
16.28%
36.85%
15.18%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States
NEW YORK